Join an AKC clinical trial today and take a step toward finding a better solution for you.
1-844-915-1364
Terms of Use Privacy Policy
© 2022 - 2024 TrialSearch / All rights reserved.
When performing clinical trials, researchers put the safety of the participants above all else. Nearly all of the trials currently enrolling are Phase 2 or Phase 3, where the initial stage of testing is complete, and the drug or treatment is determined as safe to expand to a larger population.
All studies we connect you with are FDA-authorized and thoroughly evaluated against ethical and safety standards. Through every phase of the process, studies seek approval from regulating entities, follow highly protective policies, and acquire informed consent from all the study volunteers.
TrialSearch has placed patients in trials across more than 175 therapeutic areas.
175
of participants said theywould participate in aclinical trial again.
89%
Actively enrolling clinical trials to choose from, with new studies added all the time.
100+
TrialSearch can match you to one of hundreds of actively enrolling clinical trials – helping you find potential new treatment options and bringing new medications and therapies to market faster. Since 2012, our team has been working side-by-side with those who suffer from chronic health conditions, helping you to find, qualify and enroll in new studies.
TrialSearch is the best way to search for and match with clinical trials recruiting in your area.
Atopic Keratoconjunctivitis Clinical Studies
Join an AKC clinical trial today and take a step toward finding a better solution for you.
PURPOSE OF ATOPIC KERATOCONJUNCTIVITIS (AKC) CLINICAL STUDIES
What Participants Say
Billie
Ionia, MI
"It’s been an awesome experience; I am still in this 5-year study."
"I felt great about being in the study. I liked the fact that the research was to help other people who suffer from the same situation."
"It’s been an awesome experience; I am still in this 5-year study."
Trials by the Numbers
Clinical Trial Safety
Daniel
Escondido, CA
Robert
Boston, MA
What Participants Say
Purpose of Atopic Keratoconjunctivitis Clinical Studies
Ann
Colorado Springs, CO
Being in the study was wonderful! The best part is that even though the study is over I have been allowed to continue receiving the study medication until it gets FDA approved! It’s really been a good experience.
I would absolutely recommend being a part of a clinical trial to anyone like me who was out of options. I would have gotten involved sooner if I had known more about studies and how they work.
It was easy to participate in.
Karen
Saint Peters, MO
"I felt great about being in the study. I liked the fact that the research was to help other people who suffer from the same situation."
Billie
Ionia, MI
"It’s been an awesome experience; I am still in this 5-year study."
Daniel
Escondido, CA
"The staff was wonderful and built a personal relationship with me, contributing immensely to my good experience in the study."
Jackie
Hendersonville, NC
"The study doctor was great, she guided me step-by-step. I had a good experience."
Princess
St. Petersburg, FL
What Participants Say
As simple as a doctor's visit
Get seen by top doctors in their field at no cost to you. Follow-up visits may be required.
Earn money for your time
Financial compensation varies by study, you can earn compensation for your time and travel.
Participants can receive new and advanced medical treatment by leading doctors and hospitals.
No-cost study-related medical care
BENEFITS OF PARTICIPATION
Billie
Ionia, MI
"I felt great about being in the study. I liked the fact that the research was to help other people who suffer from the same situation."
Robert
Boston, MA
"I would absolutely recommend being a part of a clinical trial to anyone like me who was out of options. I would have gotten involved sooner if I had known more about studies and how they work."
Jackie
Hendersonville, NC
"The staff was wonderful and built a personal relationship with me contributing immensely to my good experience in the study."
What Participants Are Saying
89% of patients would participate in a trial again. Here are a few experiences that past participants have shared:
